Aarti Drugs Overview
- Year Founded
-
1984
- Status
-
Public
- Employees
-
2,831
- Stock Symbol
-
524348
- Share Price
-
$5.40
- (As of Friday Closing)
Aarti Drugs General Information
Description
Aarti Drugs Ltd is engaged in the business of manufacturing and marketing finished pharmaceutical formulations. The Company is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and speciality chemicals, with products spanning therapeutic segments that include antibiotic, antiprotozoal, anti-inflammatory, antidiabetic, and antifungal therapies. The operations of the Company are limited to one segment, i.e., manufacturing of API (Active Pharmaceutical Ingredients). The Company operates in India and outside India, with India generating the maximum revenue.
Contact Information
Website
www.aartidrugs.comCorporate Office
- Mahendra Industrial Estate, Ground floor
- Road No 29, Plot No 109-D, Sion
- Mumbai, Maharashtra 400022
- India
Corporate Office
- Mahendra Industrial Estate, Ground floor
- Road No 29, Plot No 109-D, Sion
- Mumbai, Maharashtra 400022
- India
Aarti Drugs Stock Performance
As of 13-Nov-2026, Aarti Drugs’s stock price is $5.40. Its current market cap is $493M with 91.3M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $5.40 | $5.44 | $3.36 - $5.61 | $493M | 91.3M | 43.4K | $0.27 |
Aarti Drugs Financials Summary
As of 30-Sep-2026, Aarti Drugs has a trailing 12-month revenue of $307M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 468,341 | 365,512 | 427,361 | 546,158 |
| Revenue | 307,492 | 285,329 | 280,157 | 303,056 |
| EBITDA | 41,809 | 35,130 | 34,417 | 38,412 |
| Net Income | 24,681 | 22,059 | 19,887 | 20,706 |
| Total Assets | 317,926 | 298,377 | 300,994 | 291,672 |
| Total Debt | 64,509 | 61,115 | 71,905 | 67,665 |
Aarti Drugs Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Aarti Drugs Comparisons
Industry
Financing
Details
Aarti Drugs Competitors (6)
One of Aarti Drugs’s 6 competitors is Sun Pharmaceutical Industries, a Corporation company based in Mumbai, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | Corporation | Mumbai, India | ||||
| Granules India | Corporation | Hyderabad, India | ||||
| V & V Pharma Industries | Corporation | Thane, India | ||||
| Laurus Labs | Formerly PE-Backed | Hyderabad, India | ||||
| Sudarshan Pharma Industries | Corporation | Mumbai, India |
Aarti Drugs Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Aarti Drugs ESG
Risk Overview
Risk Rating
Updated July, 31, 2025
33.07 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,271
Rank
Percentile
Pharmaceuticals
Industry
of 908
Rank
Percentile
Pharmaceuticals
Subindustry
of 406
Rank
Percentile
Aarti Drugs FAQs
-
When was Aarti Drugs founded?
Aarti Drugs was founded in 1984.
-
Where is Aarti Drugs headquartered?
Aarti Drugs is headquartered in Mumbai, India.
-
What is the size of Aarti Drugs?
Aarti Drugs has 2,831 total employees.
-
What industry is Aarti Drugs in?
Aarti Drugs’s primary industry is Pharmaceuticals.
-
Is Aarti Drugs a private or public company?
Aarti Drugs is a Public company.
-
What is Aarti Drugs’s stock symbol?
The ticker symbol for Aarti Drugs is 524348.
-
What is the current stock price of Aarti Drugs?
As of 13-Nov-2026 the stock price of Aarti Drugs is $5.40.
-
What is the current market cap of Aarti Drugs?
The current market capitalization of Aarti Drugs is $493M.
-
What is Aarti Drugs’s current revenue?
The trailing twelve month revenue for Aarti Drugs is $307M.
-
Who are Aarti Drugs’s competitors?
Sun Pharmaceutical Industries, Granules India, V & V Pharma Industries, Laurus Labs, and Sudarshan Pharma Industries are some of the 6 competitors of Aarti Drugs.
-
What is Aarti Drugs’s annual earnings per share (EPS)?
Aarti Drugs’s EPS for 12 months was $0.27.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
